Proair hfa and Mirabegron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Proair hfa (albuterol sulfate) and Mirabegron (mirabegron). Common drug interactions include antibiotic therapy among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Proair hfa and Mirabegron. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

On Jul, 16, 2026

13 people who take Proair hfa and Mirabegron together, and have interactions are studied.

Proair hfa and Mirabegron drug interactions.

What are the common drug interactions of Proair Hfa and Mirabegron, by gender? *:

female:

Antibiotic therapy
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chronic kidney disease
Colitis (inflammation of colon)
Death
Encephalitis (inflammation of the brain)
Fatigue (feeling of tiredness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Renal failure (kidney dysfunction)
Thyroiditis (inflammation of thyroid gland)

male:

Asthenia (weakness)
Acute lung injury
Delirium (wild excitement)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Epistaxis (bleed from the nose)
Essential hypertension (primary hypertension)
Essential tremor
Fatigue (feeling of tiredness)
Headache (pain in head)
Hyperlipidaemia (presence of excess lipids in the blood)

What are the common drug interactions of Proair Hfa and Mirabegron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Fatigue (feeling of tiredness)

50-59:

n/a

60+:

Asthenia (weakness)
Chills (felling of cold)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Renal failure (kidney dysfunction)
Thyroiditis (inflammation of thyroid gland)
Chronic kidney disease
Colitis (inflammation of colon)
Confusional state
Drug hypersensitivity
Encephalitis (inflammation of the brain)

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 30.77%
Renal Tubular Necrosis (death of kidney tubules): 3 people, 23.08%
Rickets (softening of bones): 1 person, 7.69%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
Pain: 1 person, 7.69%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.69%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 7.69%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Proair hfa and Mirabegron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously